Zobrazeno 1 - 10
of 258
pro vyhledávání: '"John P Plastaras"'
Autor:
Uri Amit, Jahan J Mohiuddin, Andrzej P Wojcieszynski, Joanna Harton, Graeme Williams, Shwetha Manjunath, Nikhil Grandhi, Abigail Doucette, John P Plastaras, James M Metz, Edgar Ben-Josef
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background With advances in understanding liver tolerance, conformal techniques, image guidance, and motion management, dose-escalated radiotherapy has become a potential treatment for inoperable hepatocellular carcinoma (HCC). We aimed to e
Externí odkaz:
https://doaj.org/article/2efda728dc2b49cb92e507f43b9e973c
Autor:
Uri Amit, Misra Shagun, John P. Plastaras, James M. Metz, Thomas B. Karasic, Maryanne J. Lubas, Edgar Ben-Josef
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-11 (2024)
Abstract Background Biliary tract cancers (BTC) are rare and aggressive malignancies originating from intrahepatic and extrahepatic bile ducts and the gallbladder. Surgery is the only curative option, but due to late-stage diagnosis, is frequently no
Externí odkaz:
https://doaj.org/article/083e2d6c89104680a9dbfaddae83b2c2
Autor:
Christopher M. Wright, MD, Alexandra D. Dreyfuss, MD, MSTR, Jonathan A. Baron, BS, Russell Maxwell, MD, Amberly Mendes, BS, Andrew R. Barsky, MD, Abigail Doucette, MPH, Jakub Svoboda, MD, Elise A. Chong, MD, Joshua A. Jones, MD, Amit Maity, MD, PhD, John P. Plastaras, MD, PhD, Ima Paydar, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 101016- (2022)
Purpose: To report objective response rates (ORR), time to local failure (TTLF), and overall survival (OS) among patients with relapsed or refractory diffuse large B-cell lymphoma after salvage- or palliative-intent radiation therapy (RT) and to inve
Externí odkaz:
https://doaj.org/article/0d4438d4dcdb461fb0d9e1426019ca55
Autor:
Alexandra D. Dreyfuss, Andrew R. Barsky, E. Paul Wileyto, Jennifer R. Eads, John C. Kucharczuk, Noel N. Williams, Thomas B. Karasic, James M. Metz, Edgar Ben‐Josef, John P. Plastaras, Andrzej P. Wojcieszynski
Publikováno v:
Cancer Medicine, Vol 10, Iss 4, Pp 1275-1288 (2021)
Abstract Objective To report outcomes and toxicity in patients who received definitive concurrent chemoradiation (DCCRT) for non‐operable esophageal cancer (EC) in the modern era, and to identify markers of overall and disease‐free survival (OS/D
Externí odkaz:
https://doaj.org/article/924e8f34f4df4c4e908245aba1ba36dc
Autor:
Nicholas R. Perkons, Casey Kim, Chris Boedec, Luke J. Keele, Charles Schneider, Ursina R. Teitelbaum, Edgar Ben‐Josef, Peter E. Gabriel, John P. Plastaras, Lawrence N. Shulman, Andrzej P. Wojcieszynski
Publikováno v:
Cancer Reports, Vol 5, Iss 1, Pp n/a-n/a (2022)
Abstract Background and Aim This study quantifies how changes in healthcare utilization and delivery during the first months of the COVID‐19 pandemic have altered the presentation, treatment, and management of patients with gastrointestinal (GI) ma
Externí odkaz:
https://doaj.org/article/7b9cfa4d0a5347d9a4336576398967b1
Autor:
Jahan J. Mohiuddin, MD, Krishan R. Jethwa, MD, Nikhil Grandhi, BS, William G. Breen, MD, Xingmei Wang, MS, Akbar Anvari, PhD, Hui Lin, PhD, Harigopal Sandhyavenu, MBBS, Abigail Doucette, MPH, John P. Plastaras, MD, PhD, William G. Rule, MD, James M. Metz, MD, Kenneth W. Merrell, MD, Terence T. Sio, MD, Jonathan B. Ashman, MD, PhD, Michael G. Haddock, MD, Edgar Ben-Josef, MD, Christopher L. Hallemeier, MD, Andrzej P. Wojcieszynski, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 5, Pp 100744- (2021)
Purpose: Concurrent chemoradiation therapy is a curative treatment for squamous cell carcinoma of the anus, but patients can suffer from significant treatment-related toxicities. This study was undertaken to determine whether intensity modulated prot
Externí odkaz:
https://doaj.org/article/d6b53d16e30d4982bc1deb6102ecb9b0
Autor:
Jonathan Baron, Christopher M. Wright, Daniel Y. Lee, Maribel Carpenter, Shwetha H. Manjunath, César A. Briceño, Elise Chong, Amit Maity, John P. Plastaras, Ima Paydar
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeRadiation therapy (RT) with doses ranging from 24 Gray (Gy) to 40 Gy is a proven treatment modality for indolent orbital adnexal lymphoma (IOAL), but recently the use of low dose RT (LDRT, defined as 2 Gy x 2 fractions) has become a notable al
Externí odkaz:
https://doaj.org/article/9ee59b7752484a129ada7e416a91094f
Autor:
Graeme R. Williams, MD, MBA, Anish A. Butala, MD, Shwetha H. Manjunath, MD, Russell J.L. Maxwell, MD, Emily J. Anstadt, MD, PhD, Adam J. Waxman, MD, Joshua A. Jones, MD, John P. Plastaras, MD, PhD, Ima Paydar, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100720- (2021)
Purpose: Myeloma lesions of the head can present with central nervous system (CNS) involvement (leptomeningeal disease or brain metastasis), cranial neuropathy (CN), or impending neurologic involvement (INI). We analyzed response and survival after p
Externí odkaz:
https://doaj.org/article/e2e2bbcdfa2441f48a165074dbc85826
Autor:
Daniel Y. Lee, Jonathan Baron, Christopher M. Wright, John P. Plastaras, Alexander E. Perl, Ima Paydar
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Gingival myeloid sarcoma (MS) refractory to induction chemotherapy is a rare clinical entity and can be treated with palliative radiation therapy (RT). However, there are few previously published reports of RT approaches for the treatment of gingival
Externí odkaz:
https://doaj.org/article/47a08bec95264e08803c70ca82db1c16
Autor:
Chirayu G, Patel, Jennifer, Peterson, Marianne, Aznar, Yolanda D, Tseng, Scott, Lester, Deanna, Pafundi, Stella, Flampouri, Pranshu, Mohindra, Rahul R, Parikh, Raymond, Mailhot Vega, Laila, Konig, John P, Plastaras, James E, Bates, Pierre, Loap, Youlia M, Kirova, Ester, Orlandi, Carola, Lütgendorf-Caucig, Georgios, Ntentas, Bradford, Hoppe
Publikováno v:
Radiotherapy and Oncology. 177:21-32
To systematically review all dosimetric studies investigating the impact of deep inspiration breath hold (DIBH) compared with free breathing (FB) in mediastinal lymphoma patients treated with proton therapy as compared to IMRT (intensity-modulated ra